Page last updated: 2024-08-22

lutetium and Cancer of Gastrointestinal Tract

lutetium has been researched along with Cancer of Gastrointestinal Tract in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (50.00)	29.6817
2010's	3 (37.50)	24.3611
2020's	1 (12.50)	2.80

Authors

Authors	Studies
Chitwood, H; Myers, A	1
de Herder, WW; Krenning, EP; Kwekkeboom, DJ	1
Forrer, F; Giovacchini, G; Müller-Brand, J; Nicolas, G	1
Ahlman, H; Arne, G; Arvidsson, Y; Dalmo, J; Forssell-Aronsson, E; Kristiansson, E; Nilsson, B; Nilsson, O	1
de Jong, M; Esser, JP; Krenning, EP; Kwekkeboom, DJ; Teunissen, JJ; Valkema, R	1
Bockisch, A; Broelsch, CE; Frilling, A; Hofmann, M; Mueller-Brand, J; Saner, F; Weber, F	1
de Herder, WW; Kam, BL; Krenning, EP; Kwekkeboom, DJ; Teunissen, JJ; Valkema, R	1
de Herder, WW; de Keizer, B; Feelders, RA; Kam, BL; Krenning, EP; Kwekkeboom, DJ; van Aken, MO; van Essen, M	1

Reviews

4 review(s) available for lutetium and Cancer of Gastrointestinal Tract

Article	Year
Somatostatin receptor-targeted radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors. Endocrinology and metabolism clinics of North America, 2011, Volume: 40, Issue:1 Topics: Animals; Antineoplastic Agents; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Lutetium; Molecular Targeted Therapy; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Yttrium Radioisotopes	2011
Targeted radiotherapy with radiolabeled somatostatin analogs. Endocrinology and metabolism clinics of North America, 2011, Volume: 40, Issue:1 Topics: Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Lutetium; Molecular Targeted Therapy; Neuroendocrine Tumors; Pancreatic Neoplasms; Patient Selection; Radiation Injuries; Radioisotopes; Radionuclide Imaging; Radiotherapy; Somatostatin; Yttrium Radioisotopes	2011
Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy. Best practice & research. Clinical gastroenterology, 2005, Volume: 19, Issue:4 Topics: Animals; Carcinoma, Neuroendocrine; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Lutetium; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Patient Selection; Pentetic Acid; Peptides, Cyclic; Quality of Life; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Peptide; Receptors, Somatostatin; Somatostatin; Treatment Outcome; Yttrium Radioisotopes	2005
Treatment of patients who have endocrine gastroenteropancreatic tumors with radiolabeled somatostatin analogues. Hematology/oncology clinics of North America, 2007, Volume: 21, Issue:3 Topics: Endocrine Gland Neoplasms; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Lutetium; Octreotide; Sensitivity and Specificity; Tomography, X-Ray Computed; Yttrium Radioisotopes	2007

Trials

1 trial(s) available for lutetium and Cancer of Gastrointestinal Tract

Article	Year
Treatment with (90)Y- and (177)Lu-DOTATOC in patients with metastatic neuroendocrine tumors. Surgery, 2006, Volume: 140, Issue:6 Topics: Adult; Aged; Carcinoma, Neuroendocrine; Female; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Lutetium; Male; Middle Aged; Octreotide; Pancreatic Neoplasms; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Radiotherapy; Treatment Outcome; Yttrium Radioisotopes	2006

Article

Year

Treatment with (90)Y- and (177)Lu-DOTATOC in patients with metastatic neuroendocrine tumors.

Surgery, 2006, Volume: 140, Issue:6

Topics: Adult; Aged; Carcinoma, Neuroendocrine; Female; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Lutetium; Male; Middle Aged; Octreotide; Pancreatic Neoplasms; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Radiotherapy; Treatment Outcome; Yttrium Radioisotopes

2006

Other Studies

3 other study(ies) available for lutetium and Cancer of Gastrointestinal Tract

Article	Year
Peptide Receptor Radionuclide Therapy: An Emerging Treatment for Gastrointestinal Neuroendocrine Tumors. Clinical journal of oncology nursing, 2020, 04-01, Volume: 24, Issue:2 Topics: Adult; Coordination Complexes; Female; Gastrointestinal Neoplasms; Humans; Lutetium; Neuroendocrine Tumors; Nurses; Octreotide; Receptors, Peptide	2020
Gastrointestinal stromal tumors (GISTs) express somatostatin receptors and bind radiolabeled somatostatin analogs. Acta oncologica (Stockholm, Sweden), 2013, Volume: 52, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Isotope Labeling; Lutetium; Male; Middle Aged; Octreotide; Protein Binding; Radiopharmaceuticals; Receptors, Somatostatin; Retrospective Studies; Somatostatin; Young Adult	2013
Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Endocrine System Diseases; Gastrointestinal Neoplasms; Humans; Lutetium; Middle Aged; Neuroectodermal Tumors, Primitive; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Radioisotopes; Retrospective Studies	2008